FEATURED CONTRIBUTED CONTENT
Bonnie Brescia and Christel Aprigliano discuss the past, present, and future of patient centricity.
Bonnie Brescia and Claire Meunier talk about integrating the patient voice in clinical research, and how wearables, ingestibles, and other technologies are supporting patient centricity.
David Laky provides an overview on integrated solutions in clinical development systems and their impact on the future of clinical research.
In this episode, Paul LeVine talks about co-pay, patient affordability, and patient engagement. There’s also a related whitepaper on this topic, which you can download from the link below.
Mark Engelhart of ACM discusses clinical trials protocols, diagnostic testing, risk-based monitoring, and adaptive trials.
In this episode, we meet with Dr. Theodore Search, PharmD, Founder and CEO of Skipta. We talk about why Skipta was started. We discuss the move to a patient centric model in the industry, how this impacts the dynamics of online medical communities, and finally, measuring success and interacting with these online communities.
As the healthcare landscape moves increasingly toward outcome-based treatment approaches, the need to gather and analyze real-world outcome data has become paramount to gauging medication effectiveness and subsequently recruiting prescribers as brand advocates. This study outlines a feedback program that provides prescribers with patient results of their treatment experience in order to better inform their therapy recommendations. The program […]
Lynn King shares some misconceptions about risk-based monitoring and offers alternative clinical monitoring strategies using RBM.
Drs. Pritchard and Chee discuss Celerion’s expansion into South Korea, KoNECT’s role in fostering clinical research in South Korea, and the advantages of conducting clinical research in South Korea.
Part 1 of the Clinical Supply Knowledge Share Series by Almac. Blinding of Investigational Products – Highlights: The Changing Product Landscape Common Trial Designs Blinding Methods – Drug Encapsulation Blinding Methods – Inhalers Other Dosage Forms – Consideration Checklists Almac’s Approach to Blinding Download this informative ebook now.
Claims data highlight a portion of script abandonment, but don’t capture patients who never get to the pharmacy. Zitter Health Insights’ new and innovative research on script abandonment not only captures all types of abandonment, including before patients even get to the pharmacy, but also provides you with the “why.” How often is abandonment mindful […]
Abhishek Shankar discusses the value of patient-centricity and and how the cloud is transforming operations in the life-sciences industry.
Dr. Esinhart discusses how Chiltern’s “Designed Around You” culture supports clients’ needs, the advantages of a mid-sized global CRO, and how technology is changing the industry.
Andrew Townshend outlines the key benefits of a strategic CRO-sponsor alliance and ways to maximize the expertise from one project to the next.
In this episode, Paul LeVine talks about a shift toward focusing on outcomes and how the patient’s voice is changing healthcare. There’s also a related whitepaper on this topic, which may be downloaded from the link below.
Michelle Petersen discusses why rare disease and orphan indications are unique, related challenges to development, and tips for common study execution.
Bill Cooney discusses how studies are becoming digital, how this impacts clinical research subjects, and how the industry needs to adapt.
PAREXEL® Informatics, Corporate Vice President Ken Faulkner discusses his company’s unique Perceptive® MyTrials solution. All along your new drug’s development path, PAREXEL® Informatics has technological innovations that make the process faster, more precise, more trackable, and more productive. PAREXEL® leads the industry in creating integrated platforms and applications specifically designed to improve how biopharmaceutical companies […]
Gregory Skalicky discusses the evolution of strategic engagements with sponsors and the benefits of working with a full-service, global CRO.
David Burnham explores ways to improve the CRO-sponsor relationship and the associated benefits of a partnership alliance and successful strategic CRO-sponsor collaboration.
Dr. Spector describes how the R&D model will change by 2025, the void in clinical research talent, and preparing for the future.
Ben McGraw of PerkinElmer discusses various trends impacting the industry from IT to data transparency and the pros and cons of virtual biotech models.
Mark Lanfear of Kelly Outsourcing and Consulting Group discusses the evolving clinical trial landscape and how the talent needs within the industry are changing.
Jim Nichols provides an overview of structured content management (SCM) and why it’s important; he also shares examples and metrics of projects and outlines the next step in the evolution of SCM.
Joseph Sgherza outlines global trends related to clinical trials for pandemic responses, innovations in logistics, and how ClinicalRM assists in pandemic situations.
The healthcare industry has been wringing its collective hands for years about the problems surrounding “patient engagement.” Beyond the fact that no one has a really good definition of what constitutes patient engagement, most everyone agrees that if you have more patient engagement, you’ll achieve better outcomes. Learn more about how co-pay programs lead to better outcomes.
Michael Pollock and Mark Cziraky discuss how their two companies’ recent collaboration and combined strengths will improve real-world outcomes/evidence and Phase IV pragmatic trials.
Dr. Hurley discusses regulatory challenges in an era of mergers and acquisitions, FDA review practices, and managing the FDA approval process.